Testing for therapeutic monoclonal antibodies

In recent years, protein based biopharmaceuticals including monoclonal antibodies (mAbs — such as Daratumumab and Rituximab), bispecific antibodies and fusion proteins have become important tools in the treatment of cancers. Understanding the critical quality attributes [...]

Prince Technologies method support service

With over thirty years of experience in developing customised solutions for research and industry customers, Prince Technologies have amassed a wealth of method and application knowledge. We are now opening up this expertise as part [...]

Welcome to AT Europe 2023

Prince Technologies are delighted to attend the Analytical Technologies Europe symposium which is being held at the Hilton Rotterdam from 10–12 May 2023. The event covers recent developments, regulatory considerations, and practical applications of analytical technologies in the biopharmaceutical [...]

Go to Top